Wellington Shields Capital Management’s Windtree Therapeutics Inc WINT Stock Holding History

Wellington Shields Capital Management’s Portfolio WINT Stock Details WINT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-1,786	Closed	-$5K	–	341
2015 Q4	$5K	Hold	1,786	–	–	﹤0.01%	309
2015 Q3	$7K	Hold	1,786	–	–	﹤0.01%	304
2015 Q2	$17K	Hold	1,786	–	–	﹤0.01%	339
2015 Q1	$30K	Hold	1,786	–	–	﹤0.01%	340
2014 Q4	$29K	Hold	1,786	–	–	﹤0.01%	332
2014 Q3	$46K	Hold	1,786	–	–	0.01%	337
2014 Q2	$44K	Hold	1,786	–	–	0.01%	355
2014 Q1	$54K	Buy	1,786 +7	+0.4%	+$236	0.01%	346
2013 Q4	$56K	Buy	+1,779	New	+$55.6K	0.01%	313

Other funds holding WINT

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Wellington Shields Capital Management's WINT Position: Q1 2016 in Review

Wellington Shields Capital Management sold out of Windtree Therapeutics Inc (WINT) in Q1 2016, closing a stake of 1,786 shares — an estimated $5K sold.

Wellington Shields Capital Management first reported a position in WINT in Q4 2013 and held it in 9 quarters. The position peaked at $56K in Q4 2013. 34 funds tracked by Wall St. Rank hold WINT as of Q1 2016.

Wellington Shields Capital Management reported no remaining Windtree Therapeutics Inc position as of Q1 2016 after selling out during the quarter.
Wellington Shields Capital Management sold 1,786 Windtree Therapeutics Inc shares in Q1 2016, an estimated $5K.
Wellington Shields Capital Management first reported a position in Windtree Therapeutics Inc in Q4 2013 and held it in 9 quarters.
Wellington Shields Capital Management's Windtree Therapeutics Inc position peaked at $56K in Q4 2013.
34 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q1 2016.

Based on Wellington Shields Capital Management's 13F filing for Q1 2016, filed 2 May 2016.